Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 617-623, March 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peery, A.
Right arrow Articles by LePage, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peery, A.
Right arrow Articles by LePage, G. A.

Nucleotide Formation from {alpha}- and ß-2'-Deoxythioguanosine in Extracts of Murine and Human Tissues1

Amnon Peery and G. A. LePage

Life Sciences Research, Stanford Research Institute, Menlo Park, California 94025, and Department of Medicine, University of Southern California, Los Angeles, California

Conditions for the conversion of {alpha}-2'-deoxythioguanosine ({alpha}-TGdR) and ß-2'-deoxythioguanosine (ß-TGdR) to nucleotides were studied in extracts of murine and human tissues. These methods were applied to assays for nucleotide formation in a series of extracts from solid tumors, neoplastic bone marrows, and normal bone marrows obtained from human patients. The results show that most of such tissue extracts can phosphorylate ß-TGdR, and an appreciable percentage of extracts from the neoplasms can also phosphorylate {alpha}-TGdR. The extracts of normal bone marrows, with one exception, did not phosphorylate {alpha}-TGdR. The DNA polymerase of several tumors incorporated nucleotides of {alpha}-TGdR and ß-TGdR into DNA. These results encourage the view that such tests on tumor biopsies might permit the selection of tumors with sensitivity to the deoxythioguanosines. It appears that an earlier finding in murine tissues, in which {alpha}-TGdR was converted to nucleotide and inhibited the tumors without marrow toxicity may carry over to human patients.

1 This work was supported by Contract No. PH 43-65-575 with the Cancer Chemotherapy National Service Center, National Cancer Institute, NIH.

Received 7/ 8/68. Accepted 11/11/68.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.